Capital Bank & Trust CO Neurocrine Biosciences Inc Transaction History

Capital Bank & Trust CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $10.3 Million - $11.9 Million	-119,922 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $96,405 - $110,247	-1,078 Reduced 0.89%	119,922 $11.7 Million
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $9.53 Million - $13 Million	-108,880 Reduced 47.36%	121,000 $11.8 Million
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $204,586 - $255,008	-2,354 Reduced 1.01%	229,880 $22 Million
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $4.44 Million - $6.23 Million	-46,128 Reduced 16.57%	232,234 $22.3 Million

Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $137,420 - $210,531	1,615 Added 0.58%	278,362 $34 Million
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $932,715 - $1.41 Million	-12,418 Reduced 4.29%	276,747 $24 Million
Q4 2019 Feb 18, 2020	SELL	$86.8 - $118.57 $227,155 - $310,297	-2,617 Reduced 0.9%	289,165 $31.1 Million
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $2.6 Million - $3.15 Million	-31,032 Reduced 9.61%	291,782 $26.3 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $7.71 Million - $9.75 Million	106,796 Added 49.44%	322,814 $27.2 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $11.7 Million - $15.4 Million	168,394 Added 353.59%	216,018 $19 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $3.25 Million - $5.91 Million	47,554 Added 67934.29%	47,624 $3.4 Million
Q2 2018 Aug 14, 2018	BUY	$75.3 - $105.99 $5,271 - $7,419	70 New	70 $7,000

628

94.4M

505K

343K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.